Home › Myasthenia Gravis › Missouri
Myasthenia Gravis clinical trials in Missouri
7 studies for Myasthenia Gravis are looking for participants at sites in Missouri.
Cities in Missouri
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- NextGen Precision Health, Columbia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT06414954KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- University of Missouri, Columbia
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06193889A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- UM Health Care - Neurology and Sleep Disorders Clinic, Columbia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT06456580Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
- NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia
Recruiting
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT07478172Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Columbia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
- University of Kansas Medical Center Research Institute, Inc., Kansas City
RecruitingPhase 1/2
Ages 18 to 74 · All sexes · Updated Feb 11, 2026 · NCT07250750Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
- NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 10, 2025 · NCT06064695From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.